Zobrazeno 1 - 3
of 3
pro vyhledávání: '"S M Nidorf"'
Autor:
A Van Broekhoven, N Mohammadnia, M J M Silvis, J Los, A T L Fiolet, T S J Opstal, A Mosterd, J W Eikelboom, S M Nidorf, W A Bax, J G P Tijssen, D P V De Kleijn, P L Thompson, S El Messaoudi, J H Cornel
Publikováno v:
European Heart Journal. 43
Background The Low-Dose Colchicine 2 (LoDoCo2) trial demonstrated that colchicine reduced major cardiovascular events in patients with chronic coronary artery disease (CAD). The effect of long-term colchicine treatment on inflammatory biomarkers and
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::eee8bf500eef6f24e14e3099d9657ac0
https://doi.org/10.1093/eurheartj/ehac544.1266
https://doi.org/10.1093/eurheartj/ehac544.1266
Autor:
N Mohammadnia, J Los, T S J Opstal, A T L Fiolet, J W Eikelboom, A Mosterd, S M Nidorf, C A Budgeon, J G P Tijssen, P L Thompson, C J Tack, S Simsek, W A Bax, J H Cornel, S El Messaoudi
Publikováno v:
European Heart Journal. 43
Background Atherosclerosis is an inflammatory disease and is accelerated by diabetes mellitus (DM). Patients with chronic coronary artery disease (CAD) who also have DM are at high risk of recurrent cardiovascular events. The role of inflammation in
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::8e931466f875f30fd3e55ddaccec0537
https://doi.org/10.1093/eurheartj/ehac544.2401
https://doi.org/10.1093/eurheartj/ehac544.2401
OBJECTIVE--To see whether patients taking an oral beta blocker at the time of admission to hospital with myocardial infarction have a reduced risk of death at 28 days. DESIGN--Retrospective analysis of data collected on patients admitted over four ye
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::9ee15f19581be79b2aad1376d38f0e6b
https://europepmc.org/articles/PMC1662014/
https://europepmc.org/articles/PMC1662014/
